Cisen Pharmaceutical Co (SHSE:603367) Accounts Payable & Accrued Expense : ¥1,067 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Cisen Pharmaceutical Co Accounts Payable & Accrued Expense?

Cisen Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥1,004 Mil) to Dec. 2023 (¥927 Mil) but then increased from Dec. 2023 (¥927 Mil) to Mar. 2024 (¥1,067 Mil).

Cisen Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥768 Mil) to Dec. 2022 (¥827 Mil) and increased from Dec. 2022 (¥827 Mil) to Dec. 2023 (¥927 Mil).

Cisen Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cisen Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cisen Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Cisen Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

700.81

874.65

768.34

827.40

927.22

Cisen Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															896.73	893.74	1,003.84	927.22	1,066.73

Cisen Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cisen Pharmaceutical Co (SHSE:603367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cisen Pharmaceutical Co Ltd (SHSE:603367) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073

Website

http://www.lkcisen.com

Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.

Cisen Pharmaceutical Co (SHSE:603367) Headlines

No Headlines